{"id":"W2346817266","doi":"10.1016/j.clml.2016.04.012","title":"Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Prednisone; Cyclophosphamide; Tolerability; Dexamethasone; Regimen; Internal medicine; Multiple myeloma; Refractory (planetary science); Gastroenterology; Peripheral neuropathy; Surgery; Chemotherapy; Adverse effect; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005668084,0.0004813686,0.001137794,0.0001049797,0.0002477361,0.00003329453,0.0001759521,0.0003249666,0.00005854683],"category_scores_gemma":[0.001951538,0.0002057362,0.0002569533,0.0002130921,0.001280379,0.0001527283,0.00008389966,0.000106236,0.00001421232],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006039221,"about_ca_system_score_gemma":0.0009406811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002250549,"about_ca_topic_score_gemma":0.0001998369,"domain_scores_codex":[0.9968117,0.0001752847,0.0009704042,0.000897885,0.0004590898,0.0006856523],"domain_scores_gemma":[0.9881351,0.009606814,0.0003667588,0.0009578043,0.000256372,0.0006771786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0251583,0.0007741332,0.2262751,0.00008849658,0.0009140695,0.0001944495,0.0001341697,2.557025e-7,0.001472196,0.00004460579,0.0002513593,0.7446929],"study_design_scores_gemma":[0.04877272,0.01353825,0.9077841,0.0003278115,0.0005388907,0.0002213914,0.0001178222,0.000417555,0.004565874,0.00007588389,0.02337218,0.0002675153],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991696,0.003683186,0.000537356,0.00108185,0.0001312314,0.002477367,0.0001618479,0.00008449485,0.0001466716],"genre_scores_gemma":[0.9783629,0.0109177,0.006644122,0.0001605843,0.000268676,0.0004879137,0.0000297282,0.0000880637,0.003040313],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7444254,"threshold_uncertainty_score":0.838968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05131108994435344,"score_gpt":0.344220347304109,"score_spread":0.2929092573597555,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}